$PAHC
PHIBRO ANIMAL HEALTH CORP

2021 Q1 Form 10-Q Financial Statement

#000110465921062450 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q2 2020 Q1
Revenue $211.7M $185.9M $210.7M
YoY Change 0.47% -8.83% 2.45%
Cost Of Revenue $142.6M $125.3M $141.2M
YoY Change 0.97% -9.6% 0.2%
Gross Profit $69.17M $60.60M $69.55M
YoY Change -0.55% -7.2% 7.17%
Gross Profit Margin 32.67% 32.6% 33.0%
Selling, General & Admin $49.03M $45.40M $48.23M
YoY Change 1.66% -14.66% 14.02%
% of Gross Profit 70.89% 74.92% 69.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.918M $8.160M $8.248M
YoY Change -4.0% 14.13% 19.88%
% of Gross Profit 11.45% 13.47% 11.86%
Operating Expenses $49.03M $45.50M $48.23M
YoY Change 1.66% -14.47% 14.02%
Operating Profit $20.13M $15.10M $21.32M
YoY Change -5.57% 24.79% -5.67%
Interest Expense $3.081M -$1.900M $3.661M
YoY Change -15.84% -34.48% -218.1%
% of Operating Profit 15.3% -12.58% 17.17%
Other Income/Expense, Net $200.0K -$100.0K
YoY Change
Pretax Income $17.78M $16.40M $18.66M
YoY Change -4.73% 78.26% -4.29%
Income Tax $5.621M $10.70M $5.163M
% Of Pretax Income 31.61% 65.24% 27.66%
Net Earnings $12.16M $5.600M $13.50M
YoY Change -9.93% -36.36% -8.78%
Net Earnings / Revenue 5.74% 3.01% 6.41%
Basic Earnings Per Share $0.30 $0.33
Diluted Earnings Per Share $0.30 $138.3K $0.33
COMMON SHARES
Basic Shares Outstanding 40.48M 40.45M
Diluted Shares Outstanding 40.50M 40.50M

Balance Sheet

Concept 2021 Q1 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.10M $91.30M $81.70M
YoY Change 13.95% 11.89% -3.77%
Cash & Equivalents $49.10M $36.34M $26.75M
Short-Term Investments $44.00M $55.00M $55.00M
Other Short-Term Assets $36.80M $37.31M $27.60M
YoY Change 33.32% 37.18% 15.0%
Inventory $206.3M $196.7M $177.3M
Prepaid Expenses
Receivables $135.6M $126.5M $151.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $471.7M $451.8M $438.2M
YoY Change 7.65% -3.08% -2.99%
LONG-TERM ASSETS
Property, Plant & Equipment $150.2M $148.1M $165.2M
YoY Change -9.09% 5.64% 22.64%
Goodwill $52.68M $52.68M
YoY Change 92.62%
Intangibles
YoY Change
Long-Term Investments $4.290M $4.219M $10.50M
YoY Change -59.14%
Other Assets $66.00M $60.48M $36.30M
YoY Change 81.81% 33.21% -16.93%
Total Long-Term Assets $333.3M $332.3M $337.9M
YoY Change -1.36% 27.55% 32.67%
TOTAL ASSETS
Total Short-Term Assets $471.7M $451.8M $438.2M
Total Long-Term Assets $333.3M $332.3M $337.9M
Total Assets $805.0M $784.1M $776.1M
YoY Change 3.73% 7.9% 9.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.80M $66.09M $68.20M
YoY Change -7.91% -9.71% 6.07%
Accrued Expenses $82.65M $72.40M $43.40M
YoY Change 90.44% 97.27% 48.12%
Deferred Revenue $1.325M $1.109M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $23.40M $18.80M $17.20M
YoY Change 36.05% 50.4% 36.51%
Total Short-Term Liabilities $168.9M $157.2M $161.2M
YoY Change 4.77% 1.97% 21.66%
LONG-TERM LIABILITIES
Long-Term Debt $356.8M $368.3M $349.9M
YoY Change 1.97% 17.44% 10.48%
Other Long-Term Liabilities $63.42M $70.40M $60.30M
YoY Change 5.17% 64.49% 38.62%
Total Long-Term Liabilities $63.42M $70.40M $410.2M
YoY Change -84.54% -80.25% 13.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $168.9M $157.2M $161.2M
Total Long-Term Liabilities $63.42M $70.40M $410.2M
Total Liabilities $589.1M $595.9M $580.7M
YoY Change 1.45% 16.68% 17.86%
SHAREHOLDERS EQUITY
Retained Earnings $205.8M $183.1M
YoY Change
Common Stock $136.7M $135.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $215.9M $188.2M $195.3M
YoY Change
Total Liabilities & Shareholders Equity $805.0M $784.1M $776.1M
YoY Change 3.73% 7.9% 9.87%

Cashflow Statement

Concept 2021 Q1 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $12.16M $5.600M $13.50M
YoY Change -9.93% -36.36% -8.78%
Depreciation, Depletion And Amortization $7.918M $8.160M $8.248M
YoY Change -4.0% 14.13% 19.88%
Cash From Operating Activities $16.63M $3.880M $26.95M
YoY Change -38.29% -73.92% 72.2%
INVESTING ACTIVITIES
Capital Expenditures -$7.490M -$10.08M -$7.850M
YoY Change -4.59% -0.4% 2.61%
Acquisitions
YoY Change
Other Investing Activities $17.36M $540.0K -$6.300M
YoY Change -375.56% -97.83% 2072.41%
Cash From Investing Activities $9.870M -$9.530M -$14.15M
YoY Change -169.75% -164.61% 77.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.55M 14.99M -10.98M
YoY Change 5.19% -287.37% 268.46%
NET CHANGE
Cash From Operating Activities 16.63M 3.880M 26.95M
Cash From Investing Activities 9.870M -9.530M -14.15M
Cash From Financing Activities -11.55M 14.99M -10.98M
Net Change In Cash 14.95M 9.340M 1.820M
YoY Change 721.43% -56.82% -61.44%
FREE CASH FLOW
Cash From Operating Activities $16.63M $3.880M $26.95M
Capital Expenditures -$7.490M -$10.08M -$7.850M
Free Cash Flow $24.12M $13.96M $34.80M
YoY Change -30.69% -44.16% 49.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
dei Entity Central Index Key
EntityCentralIndexKey
0001069899
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Registrant Name
EntityRegistrantName
PHIBRO ANIMAL HEALTH CORP
CY2021Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2020Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1840497
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2023-02-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36410
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
dei Entity Address Address Line1
EntityAddressAddressLine1
Glenpointe Centre East, 3rd Floor
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07666-6712
dei Entity Address Address Line2
EntityAddressAddressLine2
300 Frank W. Burr Boulevard, Suite 21
dei Entity Address City Or Town
EntityAddressCityOrTown
Teaneck
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
329-7300
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
PAHC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Revenues
Revenues
211729000
CY2020Q1 us-gaap Revenues
Revenues
210739000
us-gaap Revenues
Revenues
613072000
us-gaap Revenues
Revenues
614471000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
142564000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
141188000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
411523000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
418153000
CY2021Q1 us-gaap Gross Profit
GrossProfit
69165000
CY2020Q1 us-gaap Gross Profit
GrossProfit
69551000
us-gaap Gross Profit
GrossProfit
201549000
us-gaap Gross Profit
GrossProfit
196318000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49033000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48232000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145839000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145243000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20132000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
21319000
us-gaap Operating Income Loss
OperatingIncomeLoss
55710000
us-gaap Operating Income Loss
OperatingIncomeLoss
51075000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2933000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3263000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8957000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10049000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
583000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
608000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3590000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1895000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17782000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18664000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50343000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39131000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5621000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5163000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13079000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11221000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12161000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
13501000
us-gaap Net Income Loss
NetIncomeLoss
37264000
us-gaap Net Income Loss
NetIncomeLoss
27910000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40483000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40463000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12161000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
13501000
us-gaap Net Income Loss
NetIncomeLoss
37264000
us-gaap Net Income Loss
NetIncomeLoss
27910000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
5749000
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-9995000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
10567000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-9999000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-9122000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-23873000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4345000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-28493000
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-144000
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-129000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-416000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-387000
CY2021Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1473000
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-2457000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2745000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-2394000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4702000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31282000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3893000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-35711000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7459000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17781000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41157000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7801000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49103000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36343000
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
44000000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
55000000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135562000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126522000
CY2021Q1 us-gaap Inventory Net
InventoryNet
206258000
CY2020Q2 us-gaap Inventory Net
InventoryNet
196659000
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
36795000
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
37313000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
471718000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
451837000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
150188000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
148109000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
64434000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
70997000
CY2021Q1 us-gaap Goodwill
Goodwill
52679000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
65998000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60478000
CY2021Q1 us-gaap Assets
Assets
805017000
CY2020Q2 us-gaap Assets
Assets
784100000
CY2021Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
23437000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
18750000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
62803000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
66091000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82651000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72397000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
168891000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
157238000
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
176000000
CY2020Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
169000000
CY2021Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
180786000
CY2020Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
199257000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
63419000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70401000
CY2021Q1 us-gaap Liabilities
Liabilities
589096000
CY2020Q2 us-gaap Liabilities
Liabilities
595896000
CY2021Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
136654000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135525000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
205755000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
183060000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-126492000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-130385000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
215921000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188204000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
805017000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
784100000
us-gaap Net Income Loss
NetIncomeLoss
37264000
us-gaap Net Income Loss
NetIncomeLoss
27910000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24042000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24177000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
662000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
662000
us-gaap Share Based Compensation
ShareBasedCompensation
1129000
us-gaap Share Based Compensation
ShareBasedCompensation
1694000
pahc Acquisition Related Items
AcquisitionRelatedItems
0
pahc Acquisition Related Items
AcquisitionRelatedItems
480000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1279000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
7293000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-676000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-389000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-620000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8410000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4009000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8091000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6584000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3746000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1841000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1019000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1369000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-751000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4159000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3550000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2693000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45236000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55471000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
50000000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
55000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
61000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
24000000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
22226000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
23969000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
54549000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
164000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1339000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11390000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110857000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
135000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
194000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
128000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
144000000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-14063000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-9486000
us-gaap Payments Of Dividends
PaymentsOfDividends
14569000
us-gaap Payments Of Dividends
PaymentsOfDividends
14563000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21632000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25951000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
546000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-1390000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12760000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30825000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36343000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57573000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49103000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26748000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188204000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8497000
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q3 us-gaap Dividends
Dividends
4854000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
192412000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25201000
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q4 us-gaap Dividends
Dividends
4855000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
564000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
213322000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7459000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2021Q1 us-gaap Dividends
Dividends
4860000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
215921000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
216015000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5032000
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2019Q3 us-gaap Dividends
Dividends
4854000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
206694000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15012000
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2019Q4 us-gaap Dividends
Dividends
4855000
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
564000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
217415000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17781000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q1 us-gaap Dividends
Dividends
4854000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
195345000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">1. Description of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, dairy and beef cattle, and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The unaudited consolidated financial information for the three and nine months ended March 31, 2021 and 2020, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the “Annual Report”), filed with the Securities and Exchange Commission on August 26, 2020 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2020, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. Although vaccines are now available, distribution efforts vary widely country-by-country and state-by-state. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may have significant economic impacts on customers, suppliers and markets. The pandemic may affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p>
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12161000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
13501000
us-gaap Net Income Loss
NetIncomeLoss
37264000
us-gaap Net Income Loss
NetIncomeLoss
27910000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40483000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40463000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
21000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
41000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
50000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q1 us-gaap Revenues
Revenues
211729000
CY2020Q1 us-gaap Revenues
Revenues
210739000
us-gaap Revenues
Revenues
613072000
us-gaap Revenues
Revenues
614471000
CY2021Q1 us-gaap Revenues
Revenues
211729000
CY2020Q1 us-gaap Revenues
Revenues
210739000
us-gaap Revenues
Revenues
613072000
us-gaap Revenues
Revenues
614471000
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
3815000
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
4570000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1325000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1109000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
221000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
220000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
662000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
662000
CY2021Q1 us-gaap Interest Expense Other
InterestExpenseOther
65000
CY2020Q1 us-gaap Interest Expense Other
InterestExpenseOther
153000
us-gaap Interest Expense Other
InterestExpenseOther
191000
us-gaap Interest Expense Other
InterestExpenseOther
441000
CY2021Q1 us-gaap Interest Expense
InterestExpense
3081000
CY2020Q1 us-gaap Interest Expense
InterestExpense
3661000
us-gaap Interest Expense
InterestExpense
9666000
us-gaap Interest Expense
InterestExpense
11431000
CY2021Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
148000
CY2020Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
398000
us-gaap Interest And Other Income
InterestAndOtherIncome
709000
us-gaap Interest And Other Income
InterestAndOtherIncome
1382000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2933000
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3263000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8957000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10049000
CY2021Q1 us-gaap Depreciation
Depreciation
5763000
CY2020Q1 us-gaap Depreciation
Depreciation
5824000
us-gaap Depreciation
Depreciation
17479000
us-gaap Depreciation
Depreciation
17395000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2155000
CY2021Q1 pahc Insurance Investment
InsuranceInvestment
5891000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2325000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6563000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6659000
CY2020Q1 pahc Amortization Of Other Assets
AmortizationOfOtherAssets
99000
pahc Amortization Of Other Assets
AmortizationOfOtherAssets
0
pahc Amortization Of Other Assets
AmortizationOfOtherAssets
123000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7918000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8248000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24042000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24177000
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
61457000
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73837000
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11587000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8881000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
133214000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
113941000
CY2021Q1 us-gaap Inventory Net
InventoryNet
206258000
CY2020Q2 us-gaap Inventory Net
InventoryNet
196659000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
CY2019Q2 us-gaap Goodwill
Goodwill
27348000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
25331000
CY2021Q1 us-gaap Goodwill
Goodwill
52679000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31842000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22873000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8245000
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11430000
CY2021Q1 us-gaap Deposits Assets
DepositsAssets
5024000
CY2020Q2 us-gaap Deposits Assets
DepositsAssets
5158000
CY2020Q2 pahc Insurance Investment
InsuranceInvestment
5801000
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
4290000
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
4219000
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
2705000
CY2021Q1 us-gaap Business Combination Indemnification Assets Amount As Of Acquisition Date
BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
0
CY2020Q2 us-gaap Business Combination Indemnification Assets Amount As Of Acquisition Date
BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
3000000
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
638000
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1021000
CY2021Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
7363000
CY2020Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
6976000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
65998000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60478000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30823000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25825000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6354000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6439000
CY2021Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6545000
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5782000
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6284000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5766000
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3466000
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3821000
CY2021Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5325000
CY2020Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5757000
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4840000
CY2021Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1135000
CY2020Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2314000
CY2021Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1360000
CY2020Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1272000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16519000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15421000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82651000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72397000
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
2860000
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Payments For Restructuring
PaymentsForRestructuring
1725000
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
1135000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27007000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17276000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12366000
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11680000
CY2021Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8463000
CY2020Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8067000
CY2021Q1 pahc International Retirement Plans
InternationalRetirementPlans
5360000
CY2020Q2 pahc International Retirement Plans
InternationalRetirementPlans
5499000
CY2021Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
1349000
CY2020Q2 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
3563000
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
261000
CY2020Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7691000
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4840000
CY2021Q1 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
0
CY2020Q2 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
546000
CY2021Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
8613000
CY2020Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
11239000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
63419000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70401000
CY2021Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-2881000
CY2020Q2 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-13448000
CY2021Q1 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-108083000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-103738000
CY2021Q1 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
22155000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
22571000
CY2021Q1 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
615000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
3256000
CY2021Q1 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2020Q2 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2021Q1 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2154000
CY2020Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2050000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-126492000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-130385000
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
204687000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
218750000
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
464000
CY2020Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
743000
CY2021Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
204223000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
218007000
CY2021Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
23437000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
18750000
CY2021Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
180786000
CY2020Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
199257000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31842000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22873000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6354000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6439000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27007000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17276000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
33361000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
23715000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M9D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y5M26D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0407
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0440
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1919000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1885000
us-gaap Operating Lease Cost
OperatingLeaseCost
5901000
us-gaap Operating Lease Cost
OperatingLeaseCost
5647000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
317000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
361000
us-gaap Variable Lease Cost
VariableLeaseCost
928000
us-gaap Variable Lease Cost
VariableLeaseCost
992000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
219000
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
196000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
622000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
613000
CY2021Q1 us-gaap Lease Cost
LeaseCost
2455000
CY2020Q1 us-gaap Lease Cost
LeaseCost
2442000
us-gaap Lease Cost
LeaseCost
7451000
us-gaap Lease Cost
LeaseCost
7252000
us-gaap Operating Lease Payments
OperatingLeasePayments
6131000
us-gaap Operating Lease Payments
OperatingLeasePayments
5529000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13882000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8591000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2047000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7047000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5143000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4101000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3320000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
18357000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
40015000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6654000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
33361000
pahc Number Of Potentially Responsible Parties
NumberOfPotentiallyResponsibleParties
140
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
142564000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
141188000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2933000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3263000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
411523000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
418153000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8957000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10049000
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Assets
Assets
805017000
CY2020Q2 us-gaap Assets
Assets
784100000

Files In Submission

Name View Source Status
0001104659-21-062450-index-headers.html Edgar Link pending
0001104659-21-062450-index.html Edgar Link pending
0001104659-21-062450.txt Edgar Link pending
0001104659-21-062450-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pahc-20210331.xsd Edgar Link pending
pahc-20210331x10q.htm Edgar Link pending
pahc-20210331x10q_htm.xml Edgar Link completed
pahc-20210331xex31d1.htm Edgar Link pending
pahc-20210331xex31d2.htm Edgar Link pending
pahc-20210331xex32d1.htm Edgar Link pending
pahc-20210331xex32d2.htm Edgar Link pending
pahc-20210331_cal.xml Edgar Link unprocessable
pahc-20210331_def.xml Edgar Link unprocessable
pahc-20210331_lab.xml Edgar Link unprocessable
pahc-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending